Theraclion SA Statistics
Want to see FR:ALTHE full AI Analyst Report?
Theraclion SA (ALTHE) Stock Statistics & Valuation Metrics
Total Valuation
Theraclion SA has a market cap or net worth of EUR 47.22M. The enterprise value is EUR 45.63M.
- Market Cap
- EUR 47.22M
- Enterprise Value
- EUR 45.63M
Share Statistics
Theraclion SA has 73,811,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 73,811,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Theraclion SA’s return on equity (ROE) is 2.20 and return on invested capital (ROIC) is -63.07%.
- Return on Equity (ROE)
- 2.20
- Return on Assets (ROA)
- -0.45
- Return on Invested Capital (ROIC)
- -63.07%
- Return on Capital Employed (ROCE)
- -0.77
- Revenue Per Employee
- 32.94K
- Profits Per Employee
- -158.06K
- Employee Count
- 36
- Asset Turnover
- 0.09
- Inventory Turnover
- 2.44
Valuation Ratios
The current PE Ratio of Theraclion SA is -6.38. Theraclion SA’s PEG ratio is -0.25.
- PE Ratio
- -6.38
- PS Ratio
- 47.98
- PB Ratio
- -122.22
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.25
Income Statement
In the last 12 months, Theraclion SA had revenue of 1.19M and earned -5.69M in profits. Earnings per share was -0.10.
- Revenue
- 1.19M
- Gross Profit
- -6.21M
- Operating Income
- -6.37M
- Pretax Income
- -6.53M
- Net Income
- -5.69M
- EBITDA
- -5.98M
- Earnings Per Share (EPS)
- -0.10
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Theraclion SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -14.00%
Stock Price Statistics
- Beta
- 1.29
- 52-Week Price Change
- 3.77%
- 50-Day Moving Average
- 0.67
- 200-Day Moving Average
- 0.61
- Relative Strength Index (RSI)
- 49.85
- Average Volume (3m)
- 107.17K
Important Dates
Theraclion SA upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 16, 2026
- Next Earnings Date
- Apr 29, 2027
- Ex-Dividend Date
- ―
Financial Position
Theraclion SA as a current ratio of 2.21, with Debt / Equity ratio of -196.64%
- Current Ratio
- 2.21
- Quick Ratio
- 1.49
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- -0.54
- Interest Coverage Ratio
- -39.35
Taxes
In the past 12 months, Theraclion SA has paid -837.00K in taxes.
- Income Tax
- -837.00K
- Effective Tax Rate
- 0.13
Enterprise Valuation
Theraclion SA EV to EBITDA ratio is -7.24, with an EV/FCF ratio of 0.00.
- EV to Sales
- 51.85
- EV to EBITDA
- -7.24
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Theraclion SA has EUR 5.22M in cash and marketable securities with EUR 4.95M in debt, giving a net cash position of EUR 272.00K billion.
- Cash & Marketable Securities
- EUR 5.22M
- Total Debt
- EUR 4.95M
- Net Cash
- EUR 272.00K
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- -EUR 0.02
Margins
Gross margin is -750.34%, with operating margin of -604.24%, and net profit margin of -665.81%.
- Gross Margin
- -750.34%
- Operating Margin
- -604.24%
- Pretax Margin
- -745.81%
- Net Profit Margin
- -665.81%
- EBITDA Margin
- -715.67%
- EBIT Margin
- -604.24%
Analyst Forecast
The average price target for Theraclion SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -16.98%
- EPS Growth Forecast
- 20.31%
Scores
- Smart Score
- ―
- AI Score
- 44
